CannaPharmaRX, Inc.
CPMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,988 | $2,584 | $2,650 | $5,065 |
| - Cash | $1 | $17 | $1 | $2 |
| + Debt | $13,381 | $17,821 | $16,764 | $14,060 |
| Enterprise Value | $15,368 | $20,388 | $19,413 | $19,123 |
| Revenue | $657 | $232 | $335 | $482 |
| % Growth | 183.5% | -30.9% | -30.5% | – |
| Gross Profit | $0 | -$621 | -$503 | -$1,691 |
| % Margin | 0% | -268.2% | -150% | -350.7% |
| EBITDA | -$961 | -$735 | -$50 | -$1,488 |
| % Margin | -146.4% | -317.3% | -14.8% | -308.6% |
| Net Income | -$1,478 | -$1,413 | -$691 | -$3,741 |
| % Margin | -225.1% | -610.3% | -206.1% | -775.9% |
| EPS Diluted | -0.002 | -0.002 | -0.001 | -0.006 |
| % Growth | -4.8% | -110% | 83.3% | – |
| Operating Cash Flow | $0 | -$446 | -$601 | -$180 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$446 | -$601 | -$180 |